Offer - Urjas Oil for just ₹ 1 X
Roczid 1000 Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Skin Infections, Pneumonia. Roczid 1000 Injection also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Roczid 1000 Injection. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Roczid 1000 Injection can also lead to other problems, which have been listed below. These side effects of Roczid 1000 Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Roczid 1000 Injection's effect is Safe during pregnancy and Safe for lactating mothers. In addition, Roczid 1000 Injection's effects on the liver, heart and kidney are discussed below in the Roczid 1000 Injection related warnings section.
Roczid 1000 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Roczid 1000 Injection in conditions like Kidney Disease. Other contraindications of Roczid 1000 Injection have been discussed in the sections ahead.
Drug reaction of Roczid 1000 Injection with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Roczid 1000 Injection is considered not safe while driving, and is not addictive.
Roczid 1000 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Roczid 1000 Injection safe for pregnant women?
Roczid is safe to take during pregnancy.
Is the use of Roczid 1000 Injection safe during breastfeeding?
Roczid is completely safe for breastfeeding women.
What is the effect of Roczid 1000 Injection on the Kidneys?
Roczid has very mild side effects on the kidneys.
What is the effect of Roczid 1000 Injection on the Liver?
Roczid is not harmful for the liver.
What is the effect of Roczid 1000 Injection on the Heart?
There are no any side effects of Roczid for the heart.
If you are suffering from any of the following diseases, you should not take Roczid 1000 Injection unless your doctor advises you to do so -
Is this Roczid 1000 Injection habit forming or addictive?
No, there is no any evidence that Roczid 1000 Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Roczid 1000 Injection, you should not drive or work on any heavy machine, as Roczid 1000 Injection can make you drowsy.
Is it safe?
Roczid 1000 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Roczid 1000 Injection in mental disorders is not effective.
Interaction between Food and Roczid 1000 Injection
Taking Roczid 1000 Injection with food is safe.
Interaction between Alcohol and Roczid 1000 Injection
Due to lack of research, there is no information about the side effects of taking Roczid 1000 Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; FORTAZ® (ceftazidime)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-312